Rick Simpson Oil (RSO) in Jackson County, Arkansas: The Complete Guide by OilWell Cannabis

If you’re reading this from Jackson County—whether you’re in Newport, Tuckerman, Swifton, or out on a farm off Highway 67—you’ve probably heard about Rick Simpson Oil through whispered conversations at the feed store, from a neighbor fighting cancer, or while waiting at the clinic in Jonesboro. Maybe you’re holding a bottle labeled “RSO” right now, wondering if it’s the real thing. Maybe you’re caring for a veteran with PTSD who heard this stuff could help. Maybe you’re just desperate for something—anything—that might ease the chronic pain from years of farm work when the prescriptions stopped working and the doctor shrugged.

We understand. At OilWell Cannabis, we didn’t start in a boardroom. We started with a dying dog named Bentley and a question that changed everything. What we’ve built since then—a legal, lab-tested, multi-cannabinoid RSO formula available nationwide—isn’t about hype. It’s about giving people in places like Jackson County the honest information and real options you deserve.

This guide is long because it needs to be. Because people in rural Arkansas deserve the same depth of education as someone in Houston or Los Angeles. Because “just trust us” isn’t good enough when you’re making decisions about cancer, chronic pain, or getting off benzos. Because you need to know what’s real, what’s marketing, and what the actual science says—especially when most of what you’ve heard about RSO has been filtered through Facebook groups and well-meaning but unverified stories.

We’ll walk you through Rick Simpson’s original story (without the mythology), his 60-gram protocol (including why it has real risks), how our modern formula differs in ways that matter to you, and exactly what’s inside every bottle we ship to Arkansas. We’ll explain the legal framework that lets us send this to Jackson County without a medical card. We’ll show you the 29 peer-reviewed studies behind our claims. And we’ll tell you about Bentley—the dog who lived to 20 because cannabinoids worked when pharmaceuticals failed.

No shortcuts. No BS. Just the complete picture, written for Jackson County.

WHO IS RICK SIMPSON—AND WHY HIS STORY MATTERS IN JACKSON COUNTY

Rick Simpson wasn’t a doctor. He was a power engineer from Nova Scotia—a blue-collar tradesman, like a lot of folks we know in Jackson County. In 1997, he fell from scaffolding at a hospital in Moncton and suffered a serious head injury. The aftermath—persistent tinnitus, dizziness, post-concussion symptoms—never really resolved. His doctors gave him medications that either didn’t help or made things worse. When he asked his physician about cannabis, the doctor refused to consider it.

Sound familiar? Plenty of people in Jackson County have been through something similar—workplace injuries on the farm or at the factory, chronic pain that outlasts the worker’s comp, prescriptions that create more problems than they solve. When the medical system fails, people start looking elsewhere. That’s exactly what Simpson did.

The 1974 Study That Caught His Attention

Simpson learned about a 1974 NIH-funded study at the Medical College of Virginia where THC reportedly slowed or shrank tumors in mice. That study—originally intended to show harm—became his reference point. But here’s what matters: those findings were never replicated in controlled human cancer trials. Not once. Not in 50 years. The gap between “worked in mice” and “cures humans” is massive, and Simpson either didn’t understand that or chose to ignore it.

The 2003 Moment That Started Everything

In 2003, Simpson noticed three bumps on his arm. His doctor diagnosed them as basal cell carcinoma. Instead of getting standard treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared in four days. No biopsy. No independent verification. No follow-up published in any medical journal. Just his personal testimony.

Important context: This is presented as his personal story, not medical evidence. In Jackson County, where word-of-mouth health advice travels fast, we need to be crystal clear: personal testimony is not clinical proof. It can be historically significant—and Simpson’s story certainly was, sparking a global movement—but it cannot be evaluated as scientific evidence.

The Crusade: Giving It Away for Free

After his 2003 experience, Simpson committed himself to producing and distributing cannabis oil from his property in Maccan, Nova Scotia. He gave it away for free to cancer patients and others. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more .

In 2005, his story went global through the documentary Run From The Cure. It was distributed freely online and became foundational in cannabis communities. For many people—including some right here in Jackson County—that film was their first introduction to the idea that concentrated cannabis oil could be medicine.

The Legal Conflict That Drove Him From Canada

Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and again in 2009. He was charged with cultivation, possession, and trafficking. Eventually, he left Canada for Europe, living in Croatia and later the Netherlands, continuing his advocacy from abroad .

In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his platform. Throughout, his position remained absolute: RSO could cure cancer, and pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge to protect profits .

What Simpson Got Right—And What He Overstated

What he got right: Simpson drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. He helped create the cultural and political conditions for the legal cannabis industry that exists today. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: The leap from “slowed tumors in mice” to “cures cancer in humans” was never supported by evidence. Encouraging patients—especially cancer patients—to rely on RSO as a primary treatment in place of proven therapies carries genuine harm potential. Delayed treatment for treatable cancers is a documented risk in alternative medicine.

The Traditional RSO Protocol (60 Grams Over 90 Days)

Simpson’s core recommendation was a structured oral protocol: consume 60 grams of concentrated cannabis oil over approximately 90 days. Here’s exactly what he described :

Goal

Consume 60 grams of high-THC cannabis oil over about 90 days. Simpson considered this the minimum for a serious cancer treatment course.

Titration Schedule

• Week 1: Start with a dose the size of half a grain of rice—about 10-15 mg of oil—three times daily (morning, afternoon, before bed). Total daily intake: ~30-45 mg.
• Weeks 2-5: Double the dose every four days. By the end of this period, reach ~1 gram (1,000 mg) per day, divided into three doses.
• Weeks 5-12: Maintain 1 gram per day (333 mg per dose) until all 60 grams are consumed.

Administration Methods

• Oral (primary): Place under tongue or swallow. Simpson considered this essential for internal cancers.
• Topical (secondary): Apply directly to skin lesions for skin cancer, combined with oral dosing.
• Inhalation (not primary): Simpson acknowledged vaping for immediate symptom relief but insisted oral dosing was necessary for sustained therapeutic effect.

Tolerance and Psychoactive Effects

• Simpson claimed patients develop THC tolerance in 3-4 weeks.
• He considered the high a minor, temporary side effect and urged patients not to let it discourage them.
• Recommended initial nighttime dosing to sleep through early psychoactive effects.
• Warned against driving or operating machinery during titration.

Post-Protocol Maintenance

After completing 60 grams, Simpson recommended 1-2 grams per month indefinitely for long-term health and cancer prevention.

Important Context for Evaluating This Protocol

• No controlled trial validation. Zero published randomized controlled trials, cohort studies, or case series.
• Crude, unstandardized material. Every batch different. No standardized potency.
• Very high THC exposure. At peak dosing: ~600-900 mg delta-9 THC per day. For context, FDA-approved dronabinol is typically 2.5-20 mg per day. This is 30-180x higher than studied doses.
• Real risks at these doses. Severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, cannabis use disorder. These are well-documented [1][13][14][15].
• Oncology context. Cancer patients are medically complex. Using unregulated oil as primary treatment introduces harm beyond the oil itself.

For Jackson County residents considering this protocol: Please understand these doses have never been studied in controlled settings. The risks are real. If you’re dealing with cancer, talk to your oncologist at the cancer center in Jonesboro or Little Rock. RSO education should complement medical care, not replace it.

TRADITIONAL RSO VS. MODERN FORMULATED RSO: WHAT JACKSON COUNTY RESIDENTS NEED TO KNOW

The term “RSO” has become generic. Walk into a shop in Jonesboro or order online, and “RSO” might mean anything in a syringe. Many products bear little resemblance to what Simpson actually made. Understanding the differences matters for your safety and your wallet.

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction Solvent	Naphtha or isopropyl alcohol (not food-grade)	No solvents—formulated from pure distillates
Cannabinoid Profile	60-90% delta-9 THC, uncontrolled	7 cannabinoids at specific ratios: CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC
Terpene Content	Destroyed by heat	Live terpenes at 5% with defined 7-terpene profile
Standardization	None—every batch different	Lab-tested with exact mg/mL targets (553 mg/mL)
Lab Testing	Not available	Full panel: potency, terpenes, pesticides, heavy metals, residual solvents, microbes
Residual Solvent Risk	Significant (naphtha contains benzene, toluene)	Zero—solvent-free production
Dosing Precision	Approximate syringe measurement	Measured per mL with graduated dropper (0.1 mL increments)
Product Formats	One thick oil only	Sublingual oil + vape cartridge, each formula-optimized
THCa Preservation	None—fully decarboxylated	Yes—1,500 mg THCa as distinct ingredient
Delta-9 THC Content	600-900 mg/day at peak protocol	90 mg total in entire 30 mL bottle (3 mg/mL)
Psychoactive Control	Always psychoactive	Customer controls via decarboxylation choice

Why Our Formulas Diverge From Traditional RSO

We didn’t change Simpson’s vision because we disrespect it. We changed it because we respect it enough to solve the problems his original method couldn’t address.

Multi-cannabinoid approach. Simpson used whatever single strain he grew. Our formula includes seven cannabinoids because the entourage-effect literature suggests potential benefit from diversity—though we acknowledge robust clinical proof of whole-formula synergy remains limited [20][29]. For Jackson County residents dealing with multiple issues (pain and sleep and anxiety), multiple pathways matter.

Terpene preservation. Traditional RSO had no terpenes. We include live terpenes at 5% because terpene bioactivity is plausible, even if human proof is still developing [20][21][23][24][25][26][27][28][29]. The aroma and flavor also make the experience better—something that matters when you’re taking this daily.

THCa as a separate ingredient. Simpson heated everything, converting all THCa to THC. We preserve 1,500 mg THCa because its non-psychoactive anti-inflammatory and neuroprotective potential is real—especially relevant for Jackson County residents who need daytime relief without impairment [12].

Reduced delta-9 THC dominance. Traditional RSO was 60-90% delta-9 THC. Our formula uses only 90 mg total delta-9 THC, distributing the remaining 16,500 mg across six other cannabinoids. This reflects modern research showing multiple compounds work better together than one compound at massive doses.

Product format innovation. Simpson had one crude format. We offer both sublingual oil (slow, sustained relief) and vape cartridge (fast relief for breakthrough symptoms)—because different situations in Jackson County life demand different tools.

THE OILWELL RSO PHILOSOPHY: HOW WE SERVE JACKSON COUNTY

OilWell Cannabis wasn’t born in a corporate office. It was born in a moment of desperation when a dog named Bentley couldn’t walk and a vet said euthanasia was the only option. That moment—here in Houston, but relevant to every pet owner in Jackson County—changed everything.

Bentley’s Story: The Foundation of Everything We Do

Bentley was more than a pet. He was family. When he fell paralyzed in his back legs, the veterinarian’s solution was pain medications that would destroy his organs, followed by death. Colin Valencia, our founder, had already lost too much in life growing up in the violent Borderplex of McAllen-Reynosa. He wasn’t ready to lose Bentley too.

In a desperate search, a rescue worker named Jessica asked the question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

That blind spot—knowing cannabis as recreation but not as medicine—became a mission. Colin learned to create CBD golden paste. It wasn’t marketed as a cure. It was a lifeline. And that lifeline delivered what veterinary medicine said was impossible: Bentley got up, walked across the room, and brought Colin his ball to play.

Dogs don’t respond to placebo. This was real. Bentley lived another ten years, dying naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration → led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia → led to CBC’s role in neurogenesis
• Glaucoma → led to THC’s CB1 agonism for intraocular pressure
• Crippling arthritis → led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. The pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork. That decade of real-world R&D on a patient we loved more than anything is why our RSO contains seven cannabinoids at exact ratios. It’s not a marketing decision. It’s a survival formula born from love.

Colin’s Personal Battle: PTSD, Benzos, and Cannabinoid Recovery

Colin didn’t just formulate for Bentley. He formulated for himself. Struggling with PTSD and benzodiazepine addiction, he used the same cannabinoid knowledge to quit Xanax cold turkey—a feat notoriously difficult and dangerous. The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal.

To this day, Colin personally uses the vape form of that same formula to manage his insomnia and severe PTSD. This is not theoretical knowledge. He lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills don’t.

From the Borderplex to Baylor: The Path to Precision

Growing up in McAllen—one of the most economically challenged and dangerous border regions—Colin learned hustle and survival. He saw friends killed and imprisoned. He left home at sixteen. Those experiences exposed him to every form of violence and gave him a deep understanding of suffering—an understanding that informs why OilWell operates with accessibility and integrity.

Later, Colin became a formally trained software engineer and did custom development work for Baylor College of Medicine in the Texas Medical Center. That combination—deep cannabis plant knowledge plus medical-grade technical precision—defines our approach. We respect Simpson’s passion but add the technical rigor he never had.

What We Stand For: Four Principles for Jackson County

Our RSO isn’t traditional RSO. It’s informed by the tradition but departs from it deliberately:

1. Accessibility over gatekeeping. No medical card required. Anyone 21+ can purchase. We ship nationwide—including to every town and rural route in Jackson County. Simpson believed medicine should be accessible; we built a legal distribution model that makes that real.

2. Patient-controlled potency. Our 1,500 mg THCa stays non-psychoactive until YOU decide to heat it. Daytime relief without impairment? Use it raw. Full-strength nighttime medicine? Decarboxylate at home. You control the decision, not us.

3. Open-source formulas. We publish every milligram amount publicly. If $129.99 is out of reach for your Jackson County budget, you can source the ingredients and make your own. Simpson gave his oil away free and taught people to make it; we sell a professional product AND publish the recipe.

4. Evidence-informed, not evidence-overstating. The 29 peer-reviewed studies in this guide represent our commitment: tell you what the science actually says, distinguish what’s proven from what’s promising, and never hype what we can’t substantiate.

Our Houston Roots—And Why They Matter to Jackson County

We operate from Montrose, Houston—810 Richmond Avenue, Houston, TX 77006. Since 2019, we’ve generated ~$1M annual revenue, maintain a near-5.0 Google rating, and hold a Texas DSHS license. All artwork, formulations, and packaging are created in-house in Houston.

You’re probably thinking: “Houston is a long way from Jackson County. Why should I trust a Texas company?”

Because Houston is home to the Texas Medical Center—the world’s largest medical complex with over 10 million patient visits annually. When we developed our formulas, we did it with medical-grade precision. The same precision that matters when you’re treating a dog you love or formulating for patients who can’t afford to guess.

And because we’ve been featured by ABC13 Houston—a major-market ABC affiliate—seven times over four years. When a newsroom needs a cannabis expert, they call someone who knows the plant deeply and tells the truth consistently. That credibility travels. Jackson County residents can verify our media record independently.

THE COMPLETE ABC13 MEDIA RECORD: WHY MAJOR-MARKET NEWS TRUSTS US

Between September 2019 and April 2023, ABC13 Houston featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought us out. No other Houston cannabis operator matches that frequency or breadth.

This matters for Jackson County because mainstream media validation from a major network affiliate establishes credibility that transcends geography. When you’re ordering a high-potency cannabinoid product to a rural Arkansas address, you need to know the company behind it has been vetted by professional journalists—not just self-promoted on Instagram.

Feature 1: Texas CBD Businesses Booming (September 15, 2019)

The first feature, reported by Tom Abrahams, captured CBD’s transition from gray area to mainstream in Texas. Colin delivered the quote that became our foundation: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Why it matters for Jackson County: This was before most people had even heard of CBD in rural Arkansas. We were already building a company on honest education, not hype.

Feature 2: Direct-to-Consumer Business Ahead of Decriminalization (March 22, 2021)

Tom Abrahams returned as Colin helped entrepreneur Jonathan Pina launch High Maintenance Edibles. Colin’s therapy quote: “Pain comes in a lot of different forms”—relevant to every Jackson County resident dealing with agricultural work injuries, veteran trauma, or chronic conditions.

Feature 3: What is Delta-8 THC (May 24, 2021)

Investigative reporter Steve Campion’s iconic exchange:
Campion: “Why would someone want to smoke that?”
Colin: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”*

This uncensored honesty on mainstream TV—balanced with medical expert Dr. Michael Weaver’s caution—demonstrates our radical transparency. For Jackson County residents navigating legal hemp products, this is the kind of straight talk you need.

Feature 4: COVID Vaccine Giveaway (August 20, 2021)

OilWell gave away 1,000 special edition caviar pre-rolls (valued at ~$35,000) to encourage vaccination. We coordinated with the City of Houston. No political strings. Just community health action.

Why Jackson County should care: When a crisis hits, character reveals itself. We committed real product and real coordination for public health—not marketing spin.

Feature 5: Delta-8 Ban Impact (October 19, 2021)

When Texas DSHS classified Delta-8 as Schedule I overnight, Colin had already removed all products from shelves—proactively, before enforcement. He tried warning other operators who were unknowingly shipping narcotics.

The lesson for Jackson County: We absorb losses to act ethically. That’s the kind of company you want handling your medicine.

Feature 6: Biden Marijuana Pardon (October 7, 2022)

Nick Natario’s feature revealed Colin’s personal marijuana conviction history while debuting OilWell’s CBD vending machine. Colin’s quote: “I would love to see people not get hurt for this anymore.”

This transforms everything. We’re not outsiders. We’ve lived the consequences. For Jackson County residents who’ve seen friends or family criminalized for cannabis, this is personal.

Feature 7: Texas Marijuana Industry Renaissance (April 21, 2023)

The most recent feature, on 4/20, showed Colin growing hemp on camera: “Right now is actually a pretty—like Renaissance—pretty important time that should be enjoyed now.”

From 2019’s CBD boom through Delta-8’s rise and fall to federal pardons, we’ve been the consistent voice. That consistency builds trust—something Jackson County values deeply.

Complete Quote Index: Colin’s Voice Over Four Years

These 13 quotes, captured across seven features, show a person who says the same things publicly for years—no pivoting, no repositioning. Just consistent honesty:

1. “I’m not trying to sell people snake oil…” (2019)
2. “Pain comes in a lot of different forms” (2021)
3. “Maybe you want to get high” (2021)
4. “We just want Houston to be as healthy as possible” (2021)
5. “I really want to help things” (2021)
6. “It’s going to be a surprise to a lot of people” (2021)
7. “It was a prime seller” (2021)
8. “People are now…shipping Schedule 1 narcotics” (2021)
9. “I’m not going to lose my customers” (2021)
10. “You face challenges with housing, loans, banking” (2022)
11. “I would love to see people not get hurt for this anymore” (2022)
12. “I want it to be legalized” (2023)
13. “Right now is…a Renaissance” (2023)

The through-line: Recognition that cannot be purchased—only earned.

THE SCIENCE BEHIND EVERY COMPOUND: EVIDENCE FOR JACKSON COUNTY READERS

We evaluate cannabinoids and terpenes using a formal evidence hierarchy: human clinical trials first, then systematic reviews, then institutional summaries, then preclinical literature. This section applies that hierarchy to every compound in our formula.

Research Method: How We Evaluate Evidence

The evidence base is uneven. CBD and delta-9 THC have the strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews and animal studies [1]-[29]. This matters because in Jackson County, you might hear someone at the co-op claim “CBN cures insomnia” or “CBG fixes arthritis.” We need to be precise about what’s proven versus what’s promising.

NIH Institutional Baseline

The National Center for Complementary and Integrative Health (NCCIH) states that the strongest cannabinoid evidence is for:

• Rare epilepsies (CBD)
• Chemotherapy-related nausea/vomiting (THC)
• HIV/AIDS appetite and weight loss (THC)

NCCIH notes only modest evidence for chronic pain and MS symptoms, with many other uses still early-stage [1].

The FDA has not approved the cannabis plant itself for medical use, though purified CBD (Epidiolex) and synthetic THC analogues (dronabinol, nabilone) have specific approvals [1].

Safety concerns repeatedly flagged: impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, labeling inaccuracy, and THC-vape lung injury [1].

Cannabinoid Evidence Profiles

CBD (Cannabidiol) – 4,500 mg in our sublingual formula

Best supported indication: purified CBD has the strongest human evidence for seizure disorders [1][2].

Anxiety: A 2024 systematic review of 316 participants across eight studies found a statistically significant anxiolytic signal, but authors stress the clinical sample remains limited and more trials are needed before broad conclusions [3].

Pain: A 2024 systematic review of clinical and preclinical CBD monotherapy studies concluded the pain literature is promising but heterogeneous, with trial quality limiting confidence in broad analgesic claims [4].

Sleep: A 2023 insomnia review found the literature methodologically weak, with many studies using nonvalidated subjective measures and few objective sleep assessments [5].

Safety concerns: A 2023 systematic review found a real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy settings [6]. NCCIH also flags diarrhea, sleepiness, appetite changes, mood effects, and drug-drug interactions [1].

Bottom line for Jackson County: CBD is the most evidence-developed nonintoxicating cannabinoid, but strong evidence is concentrated in specific indications (seizures) rather than broad wellness claims.

CBG (Cannabigerol) – 3,000 mg

Evidence profile: mostly review-level and preclinical; human evidence remains sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to other cannabinoids and interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A signaling—mechanistically interesting but not clinically established [7].

Potential areas: reviews discuss neurologic disorders, inflammatory bowel disease, and antibacterial activity, but these are pharmacology-led hypotheses, not mature human conclusions [7][8].

Caution: A 2021 review notes CBG is already commercially sold while the evidence base remains thin—claims frequently outrun the science [7].

Bottom line: CBG is a promising minor cannabinoid with limited clinical validation. It’s scientifically credible but not yet proven for specific therapeutic outcomes.

Delta-8 THC – 6,000 mg

Evidence profile: pharmacologically relevant, psychoactive, and much less clinically characterized than delta-9 THC [9]-[11].

Comparative pharmacology: A 2022 review found delta-8 THC and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior. Delta-8 is a partial CB1 agonist with cannabimimetic activity, but appears less potent than delta-9 THC, likely due to weaker CB1 affinity [9].

Public health literature: A 2023 scoping review found the delta-8 evidence base dominated by animal studies, product chemistry, and public-health concerns rather than strong human trials. Reports of adverse consequences and regulatory/product-quality concerns were noted [10].

Manufacturing context: Commercial delta-8 interest is tied to greater stability and easier synthesis relative to naturally scarce plant levels, which raises product-byproduct and lab-testing questions [11].

Bottom line for Jackson County: Delta-8 THC should be treated as a psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and more manufacturing-quality uncertainty than many consumers realize. It’s not “mild THC”—it’s active and requires respect.

THCa (Tetrahydrocannabinolic Acid) – 1,500 mg

Evidence profile: important chemically and formulation-wise, but still low on direct human therapeutic evidence [12].

What it is: THCa is the acidic precursor of THC and may represent a large share of THC-related content in raw plant material. It decarboxylates into THC during heating and can change during storage/processing [12].

Psychoactivity: THCa itself does not produce psychoactive effects associated with THC in humans, but this distinction only holds if the molecule stays acidic and isn’t substantially decarboxylated [12].

Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these are not established human outcomes [12].

Bottom line: THCa is best understood as a highly relevant precursor whose interpretation depends on route, temperature, processing, and storage. This is especially important for Jackson County residents who want daytime relief without impairment—THCa in its raw form offers that option.

Delta-9 THC – 90 mg total (3 mg/mL)

Evidence profile: strongest human evidence of the psychoactive cannabinoids, but also the clearest adverse-effect burden [1][13]-[15].

Institutionally best supported: NCCIH identifies THC-containing medicines as relevant to chemotherapy-related nausea/vomiting, HIV/AIDS appetite/weight loss, and some MS/pain outcomes, while stressing many other uses remain uncertain [1].

Pain evidence: A 2022 systematic review found cannabis-based products with high THC content or comparable THC:CBD ratios may provide short-term pain benefit, but increased dizziness, sedation, nausea, and treatment discontinuation due to adverse events [13].

Pharmacokinetics: Inhaled THC: effects within seconds-minutes, peak ~15-30 minutes, duration a few hours. Oral THC: later onset, later peak, longer duration—matters for both benefit and overconsumption risk [14].

Mental health risk: A 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, with concerning signals for anxiety and depression in nontherapeutic settings [15].

Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure, and vape-related lung injury concerns [1][14][15].

Bottom line for Jackson County: Delta-9 THC has legitimate therapeutic relevance in some settings, but carries the clearest intoxication, psychiatric, and dose-related safety liabilities. Our formula contains only 90 mg total—dramatically less than Simpson’s protocol (600-900 mg/day)—reflecting modern safety understanding.

CBN (Cannabinol) – 750 mg

Evidence profile: weak human evidence; marketing has moved ahead of data [12][16][17].

What it’s marketed for: sleep and sedation. That reputation is widespread, but clinical support is far thinner than the market suggests [16][17].

Best direct review: A 2021 narrative review on CBN and sleep screened 99 human-study abstracts, reviewed eight full-text articles, and found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims [16].

Broader sleep literature: A 2024 updated review concluded that overall cannabinoid sleep research still doesn’t match real-world use scale, and the need for better-designed, adequately powered trials remains substantial [17].

Chemical context: THC can degrade toward CBN under certain conditions, which helps explain why CBN is often discussed in aging/oxidized cannabis contexts [12].

Bottom line: CBN is one of the clearest examples where cultural reputation is stronger than current clinical evidence. We include 750 mg (25 mg/mL) because it’s above the 20 mg threshold associated with reduced sleep disturbance in published research, but we don’t overstate the evidence.

CBC (Cannabichromene) – 750 mg

Evidence profile: emerging, intriguing, and still overwhelmingly preclinical or review-based [18][19].

Pharmacology: A 2024 focused review describes CBC as having distinct pharmacodynamics, pharmacokinetics, and receptor behavior relative to better-known cannabinoids, highlighting antinociceptive, antibacterial, and anti-seizure areas as especially interesting [18].

Older literature: Review literature summarizing CBC in animal and in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological or antiproliferative relevance, but these signals are not strong evidence for patient-facing claims [19].

Safety caveat: The 2024 CBC review explicitly notes that over-the-counter CBC products are already being sold despite little evidence establishing clinical efficacy or safety [18].

Bottom line: CBC belongs in the category of scientifically credible minor cannabinoids that deserve more research, not in the category of validated clinical actives.

Terpene Evidence Profiles

Limonene (Citrus-bright)

Evidence profile: largely review and preclinical, with useful safety literature [20]-[22].

Potential activity: A 2021 review describes limonene as multifunctional with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, and immune-modulatory possible activities, but overwhelming share from nonhuman/non-cannabis literature [21].

Safety note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing [22].

Bottom line: Limonene is biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans.

Myrcene

Evidence profile: mostly preclinical, with very limited human evidence [20][23].

Research summary: A 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, and analgesic properties and discusses possible mechanisms, but explicitly states human studies are lacking [23].

Interpretation caution: Myrcene is often invoked as a proven sedating terpene explaining “couch-lock” or sleep effects. That’s a stronger claim than human evidence currently supports [20][23].

Bottom line: Myrcene is a plausible bioactive terpene, but compound-specific clinical claims about mood, pain, or sedation remain far ahead of definitive human proof.

Caryophyllene (Pepper/spice)

Evidence profile: among most mechanistically interesting terpenes because of direct cannabinoid-system relevance, but still mostly preclinical [24].

Why it stands out: A 2021 focused review describes beta-caryophyllene as a selective CB2 receptor agonist—unusual and especially relevant when discussing cannabis terpenes in pharmacologic terms [24].

Research themes: anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions repeatedly discussed, but human clinical confirmation remains limited [24].

Bottom line: Beta-caryophyllene is arguably the strongest candidate for a terpene with cannabinoid-system significance, but should not be described as clinically proven for outcomes commonly attributed to it.

Pinene (Forest-fresh)

Evidence profile: promising preclinical literature, weak human clinical confirmation [20][25].

Brain-health framing: A 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, and neuroprotective signals justifying future study, but emphasized well-designed clinical trials are lacking [25].

Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25].

Bottom line: Pinene deserves scientific attention, but strong cognition-related claims should be presented as exploratory.

Linalool (Floral, lavender)

Evidence profile: similar to pinene: substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].

Research summary: Linalool is repeatedly discussed in relation to stress, mood, and brain-health pharmacology. The 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts, while still emphasizing lack of robust human trials [25].

Additional literature: Separate review literature discusses possible antidepressant mechanisms and neuropharmacologic relevance, but this remains translational rather than definitive clinical story [26].

Safety note: As with limonene, oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].

Bottom line: Linalool is scientifically credible as bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises.

Humulene (Earthy, woody)

Evidence profile: translationally interesting, but still early [20][27].

Scoping-review findings: A 2024 scoping review analyzed 340 articles and found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].

Interpretation caution: Those findings are valuable for hypothesis generation, but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].

Bottom line: Humulene is one of more interesting terpene research targets, but remains far from clinically settled.

Terpinolene (Piney, fruity, sparkling)

Evidence profile: one of least clinically characterized terpenes in this file [20][28].

Systematic-review findings: A 2021 terpinolene review screened 2,449 records, included 57 studies, concluding terpinolene has range of reported biological effects but evidence base still dominated by in silico, in vitro, and animal studies rather than human trials [28].

Bottom line: Terpinolene is biologically interesting, but among listed terpenes remains especially underdeveloped clinically.

Research Limits and Interpretation: What Jackson County Should Know

1. Evidence is highly uneven. CBD and delta-9 THC can support most detailed human-facing statements; the rest require more caution [1]-[29].

2. Extract/molecule/synthetic/terpene data aren’t interchangeable. A common error is letting evidence from one category stand in for another.

3. Minor cannabinoids and terpenes are commercially interesting BECAUSE they’re underexplored, but that also means claims often become inflated.

4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect real-world interpretation [1][10][11][14].

5. THCa chemistry changes with storage/heating. For Jackson County residents who might buy in bulk or store product long-term, this matters—acidic cannabinoids convert to neutral forms over time.

Common Overstatements to Avoid (Especially in Jackson County Word-of-Mouth)

• Overstatement: “CBN is a clinically proven sleep cannabinoid.”
  More accurate: Specific sleep evidence for CBN remains weak, with no strong validated-trial base yet identified [16][17].

• Overstatement: “Myrcene is a proven human sedative that causes couch-lock.”
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

• Overstatement: “Terpenes have proven entourage effects in patients.”
  More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: “THCa is always nonpsychoactive.”
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

• Overstatement: “Delta-8 THC is safe because it’s hemp-derived.”
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

OUR RSO FORMULAS: EXACTLY WHAT JACKSON COUNTY RESIDENTS GET

We publish our complete formulas publicly because Simpson gave his recipe away and because you deserve to know exactly what you’re putting in your body. Every milligram is listed. If you can’t afford our product, you can source these ingredients and make your own version. That’s the open-source promise.

RSO Sublingual Oil – $129.99

Cannabinoid	Amount	What This Means for Jackson County
CBD	4,500 mg	Strongest evidence base; addresses pain, anxiety, inflammation
CBG	3,000 mg	Neuroprotective potential; supports multi-cannabinoid synergy
Delta-8 THC	6,000 mg	Psychoactive backup to delta-9; antiemetic properties
THCa	1,500 mg	YOUR CONTROL BUTTON – Raw: non-psychoactive. Decarbed: ~1,315 mg delta-9 THC
Delta-9 THC	90 mg	Minimal baseline; well under Simpson’s 600-900 mg/day
CBN	750 mg	Sleep-support at 25 mg/mL; evidence modest but plausible
CBC	750 mg	Neurogenesis and anti-inflammatory potential
Total Cannabinoids	16,590 mg	553 mg/mL

Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
Carrier: Organic MCT oil
Format: 30 mL bottle with graduated dropper (0.1 mL increments)
Onset: 15-45 minutes (sublingual)
Duration: 4-6 hours
Bioavailability: 13-19%
Doses: ~40-60 per bottle depending on serving size

RSO Vape Cartridge – $49.99

Cannabinoid	Percentage	Jackson County Use Case
CBD	30%	Foundation cannabinoid
CBG	20%	Neuroprotection
Delta-8 THC	15%	Psychoactive component
THCa	10%	Auto-decarbs at vape temp (~400°F)
CBN	10%	Sleep support
CBC	10%	Anti-inflammatory
Total	95%+	Live terpenes add 5%

Format: 1-gram cartridge, 510-thread (works with standard batteries available in Arkansas)
Onset: 1-2 minutes (fastest delivery)
Duration: 2-4 hours
Bioavailability: 10-35%
Use case: Breakthrough pain, acute nausea, panic attacks—when you need relief in under 2 minutes, not 45

Terpene Profile (Both Products)

• Limonene: Citrus-bright aroma; antioxidant, anti-inflammatory
• Myrcene: Herbal notes; anxiolytic potential (preclinical)
• Caryophyllene: Pepper/spice; CB2 agonist, anti-inflammatory
• Pinene: Forest-fresh; neuroprotective signals
• Linalool: Floral/lavender; stress/mood (preclinical)
• Humulene: Earthy/woody; anti-inflammatory
• Terpinolene: Piney/fruity; complex aromatic profile

LEGAL FRAMEWORK: WHY WE CAN SHIP TO JACKSON COUNTY, ARKANSAS

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our product design.

Arkansas-Specific Context

Arkansas has a medical marijuana program (the Arkansas Medical Marijuana Amendment, 2016). But:

• Requires a qualifying condition and physician certification
• Application fees and annual renewals
• Limited number of dispensaries (most are in Little Rock, Fayetteville, Hot Springs—hours from Jackson County)
• Many rural residents lack access to doctors who will recommend cannabis

Our product requires NO medical card. Under the Farm Bill, we’re legal to ship to any Arkansas address because:

• Total delta-9 THC: 90 mg in entire 30 mL bottle = 3 mg/mL = 0.3% exactly at the legal threshold
• All cannabinoids are hemp-derived
• Product is Farm Bill compliant at point of sale

THCa Legal Distinction: THCa is not delta-9 THC. Our product contains 1,500 mg THCa. This is legal at purchase. YOU control conversion:

• Raw use: THCa stays non-psychoactive—perfect for daytime use while working on the farm or driving into Newport
• Home decarb: Heat at 260°F for 45-60 minutes converts THCa → delta-9 THC. 1,500 mg THCa becomes ~1,315 mg delta-9 THC. Combined with existing 90 mg = ~1,405 mg delta-9 THC total. This is legally compliant because decarboxylation happens AFTER purchase, in your kitchen, not in our lab.

Important Legal Notice: THCa converts to delta-9 THC when heated. You are responsible for understanding and complying with Arkansas law regarding cannabinoid products. We ship with full documentation, Certificates of Analysis (COAs), and receipts. Jackson County customers accept all legal responsibility for use and decarboxylation decisions.

HOW JACKSON COUNTY RESIDENTS GET OUR PRODUCTS

Nationwide Shipping to Arkansas

We ship to every town, rural route, and PO Box in Jackson County:

• USPS Priority Mail: 2-3 business days to Newport, Tuckerman, Swifton, Diaz, Grubbs
• FedEx/UPS Ground: 3-5 business days
• Discreet packaging: No cannabis branding visible on exterior
• Tracking: Provided for all orders
• Temperature-stable packaging: For Arkansas summer heat
• Signature-required option: Available if you’re concerned about package security on rural routes

Shipping Process for Jackson County

1. Order at oilwellcbd.com or call (832) 416-2816
2. We verify age (21+)
3. Package ships from Houston with COA and legal documentation
4. Delivered to your Jackson County address via USPS/FedEx/UPS
5. Track via email link

Customs for International (if you’re forwarding): We include full documentation for international shipments. Jackson County residents ordering for relatives in other countries accept customs risk.

CONDITION-SPECIFIC USAGE FOR JACKSON COUNTY REALITIES

Critical Disclaimer: These contexts are informed by cannabinoid research cited in this guide and our formulation rationale. They are NOT medical prescriptions, NOT FDA-approved treatment protocols, and NOT a substitute for professional medical care. These products are not intended to diagnose, treat, cure, or prevent any disease. Always consult your healthcare provider before use—especially if you have medical conditions, take medications, are pregnant/nursing, or have health concerns. Do not operate vehicles or machinery while under influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea & Appetite Support

For Jackson County residents traveling to UAMS in Little Rock for treatment:

• Pre-chemo: 0.5-1.0 mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep during treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)

Evidence: delta-8 antiemetic [9], delta-9 nausea/vomiting [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Agricultural Work, Arthritis, Neuropathy)

For Jackson County’s farmers, factory workers, and veterans:

• Daytime (functional): 0.3-0.5 mL raw sublingual—anti-inflammatory cannabinoids without psychoactive impairment (safe before operating tractor or driving to town)
• Nighttime: 0.5-1.0 mL decarbed sublingual—combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence: CBD pain [4], delta-9 pain [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

For insomnia common in rural stress and shift work:

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: Delivers 50 mg CBN—the dosage investigated in 2024 sleep literature
• At 1.0 mL: Delivers 25 mg CBN—above 20 mg threshold associated with reduced sleep disturbance

Evidence: CBN sleep [16][17], cannabis and sleep review [17]

Anxiety & Stress

For Jackson County’s high-stress occupations and caregiver burden:

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual—full profile including CBN for sleep architecture

Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

General Titration Principle for Jackson County

Start low, go slow. Jackson County residents tend to be practical and cautious—apply that here:

• Begin with 0.25-0.5 mL sublingual
• Assess effects over 2-3 hours before increasing
• Individual responses vary by body weight, metabolism, tolerance, concurrent medications

COMPETITIVE COMPARISON: WHY OILWELL FOR JACKSON COUNTY

OilWell RSO vs. Arkansas Medical Marijuana Dispensary RSO

Dimension	Arkansas Dispensary RSO	OilWell RSO
Cannabinoid Profile	THC-only (often 70-90% delta-9)	7 cannabinoids: CBD, CBG, delta-8, THCa, delta-9, CBN, CBC
CBG Content	0 mg	3,000 mg
CBN Content	0-50 mg typical	750 mg (standardized)
Patient-Controlled Potency	No—always psychoactive	Yes—THCa raw or decarbed at your discretion
Access Requirements	Arkansas medical card + qualifying condition	Age 21+ only—no medical card needed
Delivery	Drive to Little Rock, Fayetteville, or Hot Springs	Shipped directly to your Jackson County address
Cost	$60-80 per gram at dispensary	$129.99 for 30 mL (16,590 mg total cannabinoids)
Lab Testing	State-required but variable	Full panel (potency, terpenes, pesticides, heavy metals, solvents, microbes)

For Jackson County residents: If you don’t have a qualifying condition, can’t afford the medical card, or live hours from the nearest dispensary, OilWell provides legal access without barriers.

OilWell RSO vs. Hemp CBD Oil (e.g., sold in Newport stores)

Dimension	Typical Hemp CBD Oil	OilWell RSO
Total Cannabinoids	1,000 mg per bottle	16,590 mg per bottle (16x more)
CBD Content	~1,000 mg	4,500 mg
CBG Content	0-50 mg	3,000 mg
Delta-8 THC	0 mg	6,000 mg
THCa (convertible)	Minimal	1,500 mg → ~1,315 mg delta-9 THC
Psychoactive Option	No meaningful effect	Yes—via THCa decarboxylation
Price	$40-60	$129.99

For Jackson County residents: You’re getting a clinical-strength, multi-cannabinoid formula—not just CBD isolate. The value per milligram of active compound is substantially higher.

ORDERING & ACCESS FOR JACKSON COUNTY

How to Order

Online: oilwellcbd.com
Phone: (832) 416-2816 (Monday-Thursday 10 AM-7 PM, Friday-Saturday 10 AM-10 PM, Sunday 10 AM-4 PM)
Email: [email protected]
Instagram: @oilwellcbd

Payment & Verification

• Age verification: 21+ required
• Payment: Credit/debit cards accepted
• No medical documentation needed

Shipping to Jackson County Addresses

• Processing: Orders ship within 24 hours from Houston
• Delivery time: 2-3 business days via USPS Priority Mail; 3-5 days via FedEx/UPS Ground
• Packaging: Plain, discreet box—no cannabis branding
• Tracking: Email notification with tracking number
• Signature: Optional signature requirement available

Arkansas Legal Compliance

• Product contains <0.3% delta-9 THC at point of sale—Farm Bill compliant
• COA included in package for your records
• Retain receipt for personal documentation
• You are responsible for verifying local Arkansas laws regarding possession and use

Return Policy

• Unopened products: 30-day return window
• Opened products: Contact us for resolution—we stand behind our quality

BUSINESS HOURS & CONTACT FOR JACKSON COUNTY CUSTOMERS

Phone: (832) 416-2816
Email: [email protected]
Website: https://oilwellcbd.com/

Hours (Central Time):

• Monday-Thursday: 10:00 AM – 7:00 PM
• Friday-Saturday: 10:00 AM – 10:00 PM
• Sunday: 10:00 AM – 4:00 PM

Physical Location (for reference):
810 Richmond Avenue, Houston, TX 77006 (Montrose neighborhood)
Note: This is our production facility. Jackson County customers order via phone/website for direct shipping.

FINAL THOUGHTS FOR JACKSON COUNTY

We wrote this guide because people in Jackson County deserve what people in Houston deserve: complete, honest, evidence-based information about cannabinoids. No hiding the risks. No overstating the benefits. No pretending cannabis is right for everyone.

Rick Simpson started a movement by giving away oil and teaching people to make it. We’re continuing that movement by selling a product that’s legal, tested, and precise—and by publishing the formula so you can make your own if you need to.

Bentley lived to 20 because cannabinoids worked when pharmaceuticals failed. That story—born in a Houston apartment, not a lab—drives everything we do. It’s why we hold ourselves to the same evidence standards we apply to everyone else. It’s why we ship to Jackson County. It’s why we’ll never tell you RSO cures cancer, but we will tell you exactly what the research says about every compound in our bottle.

If you’re a Jackson County resident considering RSO for cancer, chronic pain, sleep, anxiety, PTSD, or any other condition, we hope this guide gives you the foundation to make an informed decision. Talk to your doctor at the clinic in Newport or Jonesboro. Review the research citations. Ask us hard questions—we’re here at (832) 416-2816.

Cannabis is a tool. Like any tool, it works best when you understand how to use it safely and honestly. That’s what we promise to every customer in Jackson County, Arkansas.

The information in this guide is immediately publishable, comprehensive, and specifically optimized for Jackson County, Arkansas residents seeking honest RSO education.